SEATTLE, Feb. 29, 2012 /PRNewswire/ — Omeros Corporation (NASDAQ: OMER – News) today announced that it has identified compounds that functionally interact with each of the following six orphan G protein-coupled receptors (GPCRs): GPR17, GPR153, CCRL2, LGR4, LGR6 and OPN5

London, Feb 29 (IANS) Children shot with their own stem cells, for the very first time in a rare immune disorder, have shown improvement. The condition, known as X-CGD, is caused by faulty genes. Doctors were able to take a sample of the children’s stem cells, manipulate them in the lab and reintroduce them.

Scientists are growing living brain cells from skin samples which could help research into treatments for schizophrenia and bipolar disorder.

Celltex hosts the largest stem-cell bank in the United States. TYLER RUDICK With Texas pouring millions of dollars into developing adult stem-cell treatments, doctors there are already injecting paying customers with unproven preparations, supplied by an ambitious new company.

close select a state: Please choose Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Current state : Not selected.

SILVER SPRING, Md.–(BUSINESS WIRE)– Nuvilex, Inc. (OTCQB:NVLX), an emerging biotechnology provider of cell and gene therapy solutions, announced today Goldman Small Cap Research has reissued its buy recommendation on Nuvilex with a short term price target of $0.50 per share. According to the research report prepared by Goldman, The current share price represents but a fraction of its true value, in our view

User comments posted on this website are the sole views and opinions of the comment writer and are not representative of Guardian Media Limited or its staff.

Scientists might have found a way for a woman to be able to produce more eggs, potentially aiding and extending her fertility. The study, published in the journal Nature Medicine, found the ovaries of young women might still contain egg-producing stem cells, according to a report by MSNBC

These human eggs (oocytes) can now be made from adult ovaries; Credit: Shutterstock Yvonne A R White, Dori C Woods, Yasushi Takai, Hiroyuki Seki and Jonathan L Tilly worked hard in 2004. When this intrepid team revealed that some mammals (eg.

Allegheny-Kiski Health Foundation will present “Stem-Cell Therapy: Defeating the Aging Process” from 6 to 8 p.m.

Regenerative Medicine Institute, Mexico has been granted full accreditation for its clinical stem cell trials Portland, Oregon (PRWEB) February 29, 2012 We are pleased that RMI undertook this process, says David Audley, executive director of the ICMS. The clinic understood that patient safety can only be assured through strict evaluation and rigorous oversight

28-02-2012 14:48 Albert Rodriguez, MD administers stem cell therapy for Hereditary Spastic Paraplegia. stemcelldrR.com, email airpainmd@aol.com

Study Aims to Deliver Adult’s Own Cells As Treatment for Chronic Myocardial Ischemia DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX) announced today that it has initiated a phase III pivotal clinical trial to evaluate the efficacy and safety of adult autologous (an individual’s own) CD34+ stem cells to increase exercise capacity in patients with chronic myocardial ischemia (CMI). Chronic myocardial ischemia (CMI) is one of the most severe forms of coronary artery disease, causing significant long-term damage to the heart muscle and disability to the patient.

(RTTNews.com) – Baxter International Inc. (BAX) said it has initiated a phase III pivotal clinical trial to evaluate the efficacy and safety of adult autologous CD34+ stem cells to increase exercise capacity in patients with chronic myocardial ischemia.

A long-held belief about women and fertility is that each woman has a set amount of eggs in her lifetime and that when those eggs are depleted at menopause, so are her chances at having a biological child. However, research out of Massachusetts General Hospital questioning that view. Using stem cells taken from human ovaries, scientists have produced early-stage eggs, which brings up all sorts of questions about possible new methods for treating infertility. Nicholas Wade, writing in the New York Times, adds, “The ability to isolate stem cells from which eggs could be cultivated would help not only with fertility but also with biologists’ understanding of how drugs and nutrition affect the egg cells.” RELATED: Gecko Foot Glue; When Alcohol Is a Health Food Jonathan Tilly, the director of Mass General’s Vincent Center for Reproductive Biology and leader of the new research, had reported in 2004 that ovarian stem cells in mice could create new eggs “similar to how stem cells in male testes produce sperm throughout a man’s life.” His new study attempted to prove this with humans.

Source: ISNA, Tehran The researches have studied mesenchymal stem cells or MSCs derived from mice bone marrow in cell culture period and succeeded to identify new division in cell latency period which can lead to chromosomal disorders in the cells.

Left-hander C.J. Nitkowski appeared in 336 games, mostly in a relief role, over parts of 10 seasons. (AP) The last known whereabouts of C.J. Nitkowski, in regard to his Major League career, was Washington, some seven years ago.

PORT WASHINGTON, N.Y.–(BUSINESS WIRE)– Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, today announced it has entered into an exclusive U.S. distribution agreement with leading animal health products provider MWI Veterinary Supply Co.

VOL. 127 | NO. 41 | Wednesday, February 29, 2012 Memphis Newsmakers By Taylor Shoptaw Updated 2:22PM Adam M.

Diverse approach to cancer research need of the hour, stresses professor Profoundly different approaches are needed for cancer research, the Qatar International Conference on Stem Cell Science and Policy 2012, has been told by an expert in cancer stem cell (CSC) biology. Professor Irving Weissman, director, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, was delivering a keynote address on ‘Normal and neoplastic stem cells’ yesterday